Metabolomic Profiling and Drug Interaction Characterization Reveal Riboflavin As a Breast Cancer Resistance Protein–Specific Endogenous Biomarker That Demonstrates Prediction of Transporter Activity In Vivo
Drug Metabolism and Disposition · 2023
DOI: 10.1124/dmd.123.001284 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2023. Verfasst von Yueping Zhang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Drug Metabolism and Pharmacokinetics (Y.Z., E.P., R.M.F., M.S., H.S.), Bioanalytical Research (P.A.S., B.M.W.), Translational Developm…. Hauptthemen laut MEDLINE: Brain, Breast Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Departments of Drug Metabolism and Pharmacokinetics (Y.Z., E.P., R.M.F., M.S., H.S.), Bioanalytical Research (P.A.S., B.M.W.), Translational Development (D.M.N.), Nonclinical Disposition and Bioanalysis (L.W., R.H., J.C…
Zitieren
APA
Zhang, Y., Shipkova, P. A., Warrack, B. M., Nelson, D. M., Wang, L., Huo, R., Chen, J., Panfen, E., Chen, X. Q., Fancher, R. M., Ruan, Q., Christopher, L. J., Xue, Y., Sinz, M., & Shen, H. (2023). Metabolomic Profiling and Drug Interaction Characterization Reveal Riboflavin As a Breast Cancer Resistance Protein–Specific Endogenous Biomarker That Demonstrates Prediction of Transporter Activity In Vivo. Drug Metabolism and Disposition. https://doi.org/10.1124/dmd.123.001284
Vancouver
Zhang Y, Shipkova PA, Warrack BM, Nelson DM, Wang L, Huo R, et al. Metabolomic Profiling and Drug Interaction Characterization Reveal Riboflavin As a Breast Cancer Resistance Protein–Specific Endogenous Biomarker That Demonstrates Prediction of Transporter Activity In Vivo. Drug Metabolism and Disposition. 2023. doi:10.1124/dmd.123.001284
BibTeX
@article{Zhang2023,
author = {Zhang, Yueping and Shipkova, Petia A and Warrack, Bethanne M and Nelson, David M and Wang, Linna and Huo, Runlan and Chen, Jian and Panfen, Erika and Chen, Xue-Qing and Fancher, R Marcus and Ruan, Qian and Christopher, Lisa J and Xue, Yongjun and Sinz, Michael and Shen, Hong},
title = {Metabolomic Profiling and Drug Interaction Characterization Reveal Riboflavin As a Breast Cancer Resistance Protein–Specific Endogenous Biomarker That Demonstrates Prediction of Transporter Activity In Vivo},
journal = {Drug Metabolism and Disposition},
year = {2023},
doi = {10.1124/dmd.123.001284}
}
EUVIMED